Pangaea Oncology SA (PANG) Stock Price & News

All values in EUR	Mrt. 2025	Jun. 2025	Sep. 2025	Des. 2025
Revenue	3,58 m	3,58 m	3,68 m	3,68 m
Cost of goods sold	642,93 k	642,93 k	648,84 k	648,84 k
Cost of revenue	642,93 k	642,93 k	648,84 k	648,84 k
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3,69 m	3,69 m	3,94 m	3,94 m
Operating expense	3,79 m	3,79 m	4,13 m	4,13 m
Total operating expenses	4,43 m	4,43 m	4,78 m	4,78 m
Operating income	-851,91 k	-851,91 k	-1,09 m	-1,09 m
Other non operating income	28,82 k	28,82 k	48,23 k	48,23 k
EBT including unusual items	-860,55 k	-860,55 k	-1,15 m	-1,15 m
EBT excluding unusual items	-860,55 k	-860,55 k	-1,15 m	-1,15 m
Income tax expense	-54,22 k	-54,22 k	-173,94 k	-173,94 k
Effective tax rate	6,30%	6,30%	15,10%	15,10%
Other operating expenses	-590,59 k	-590,59 k	-511,29 k	-511,29 k
Net income	-846,30 k	-846,30 k	-951,76 k	-951,76 k
Net profit margin	-23,65%	-23,65%	-25,84%	-25,84%
Earnings per share	-	-	-	-
Interest and investment income	583,00	583,00	-	-
Interest expense	-51,44 k	-51,44 k	-97,69 k	-97,69 k
Net interest expenses	-50,86 k	-50,86 k	-97,69 k	-97,69 k
Depreciation and amortization charges	689,26 k	689,26 k	700,90 k	700,90 k
EBITDA	-521,46 k	-521,46 k	-779,73 k	-779,73 k
Gain or loss from assets sale	-	-	-	-

Ask anything